Immunology as it pertains to drugs of abuse, AIDS and the neuroimmune axis: Mediators and traffic

Journal of Neuroimmune Pharmacology

Volumn 6, Issue 1, 2011, Pages 20-27

  Rogers, Thomas J ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AIDS; Drugs of abuse; HIV; Neuroimmune axis

Indexed keywords

GAMMA INTERFERON;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BLOOD BRAIN BARRIER; DRUG ABUSE; DRUG ACTIVITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NEUROIMMUNOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 79251561249     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-010-9247-2     Document Type: Review

References (44)

1. Gendelman HE, Grant I, Everall IP, Lipton SA, and Swindells S (eds) (2005) The neurology of AIDS, 2nd ed. Oxford University Press, ISBN: 0-19-852610-5
2. Ikezu T, Gendelman HE (eds) (2008) An overview: neuroimmune pharmacology. Springer Science, New York
3. AW Segal 2005 How neutrophils kill microbes Annu Rev Immunol 23 197 223 1:CAS:528:DC%2BD2MXktFOjtbY%3D 10.1146/annurev.immunol.23.021704.115653 15771570 (Pubitemid 40563169)
4. O Soehnlein L Lindbom 2010 Phagocyte partnership during the onset and resolution of inflammation Nat Rev Immunol 10 427 439 1:CAS:528: DC%2BC3cXmsVWmsLs%3D 10.1038/nri2779 20498669
5. GM Barton JC Kagan 2009 A cell biological view of toll-like receptor function: regulation through compartmentalization Nat Rev Immunol 9 535 542 1:CAS:528:DC%2BD1MXnslKqtrs%3D 10.1038/nri2587 19556980
6. CA Dinarello 2009 Immunological and inflammatory functions of the interleukin-1 family Annu Rev Immunol 27 519 550 1:CAS:528:DC%2BD1MXlsFSltrc%3D 10.1146/annurev.immunol.021908.132612 19302047
7. B-H Luo CV Carman TA Springer 2007 Structural basis of integrin regulation and signaling Annu Rev Immunol 25 619 647 1:CAS:528: DC%2BD2sXltlansrc%3D 10.1146/annurev.immunol.25.022106.141618 17201681 (Pubitemid 46697919)
8. JE Sims DE Smith 2010 The IL-1 family: regulators of immunity Nat Rev Immunol 10 89 102 1:CAS:528:DC%2BC3cXntVCrsQ%3D%3D 10.1038/nri2691 20081871
9. TH Watts 2005 TNF/TNFR family members in costimulation of T cell responses Annu Rev Immunol 23 23 68 1:CAS:528:DC%2BD2MXktFOjtb0%3D 10.1146/annurev.immunol.23.021704.115839 15771565 (Pubitemid 40563164)
10. F Castellino RN Germain 2006 Cooperation between CD4+ and CD8+ T cells: when, where, and how Annu Rev Immunol 24 519 540 1:CAS:528:DC%2BD28XkvFSqtLs%3D 10.1146/annurev.immunol.23.021704.115825 16551258
11. J Zhu H Yamane WE Paul 2010 Differentiation of effector CD4 T cell populations Annu Rev Immunol 28 445 489 1:CAS:528:DC%2BC3cXlsVSmsL4%3D 10.1146/annurev-immunol-030409-101212 20192806
12. Y Belkaid K Tarbell 2009 Regulatory T cells in the control of host-microorganism interactions Annu Rev Immunol 27 551 589 1:CAS:528: DC%2BD1MXlsFSlt74%3D 10.1146/annurev.immunol.021908.132723 19302048
13. GJ Randolph J Ochando S Partida-Sanchez 2008 Migration of dendritic cell subsets and their precursors Annu Rev Immunol 26 293 316 1:CAS:528: DC%2BD1cXltlWksbg%3D 10.1146/annurev.immunol.26.021607.090254 18045026 (Pubitemid 351600378)
14. S Sakaguchi M Miyara CM Costantino DA Hafler 2010 FoxP3+ regulatory T cells in the human immune system Nat Rev Immunol 10 490 500 1:CAS:528: DC%2BC3cXnsFKitLY%3D 10.1038/nri2785 20559327
15. DL Woodland JE Kohlmeier 2009 Migration, maintenance and recall of memory T cells in peripheral tissues Nat Rev Immunol 9 153 161 1:CAS:528: DC%2BD1MXit1yjsLs%3D 10.1038/nri2496 19240755
16. C Auffray MH Sieweke F Geissmann 2009 Blood monocytes: development, heterogeneity, and relationship with dendritic cells Annu Rev Immunol 27 669 692 1:CAS:528:DC%2BD1MXlsFSlt70%3D 10.1146/annurev.immunol.021908.132557 19132917
17. F Geissmann S Gordon DA Hume AM Mowatt GJ Randolph 2010 Unravelling mononuclear phagocyte heterogeneity Nat Rev Immunol 10 453 460 1:CAS:528:DC%2BC3cXlvFOkurY%3D 10.1038/nri2784 20467425
18. FO Martinez L Helming S Gordon 2009 Alternative activation of macrophages: an immunologic functional perspective Annu Rev Immunol 27 451 483 1:CAS:528:DC%2BD1MXlsFSltrk%3D 10.1146/annurev.immunol.021908.132532 19105661
19. JW Pollard 2009 Trophic macrophages in development and disease Nat Rev Immunol 9 259 270 1:CAS:528:DC%2BD1MXjtFCisbc%3D 10.1038/nri2528 19282852
20. A Ma R Koka P Burkett 2006 Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis Annu Rev Immunol 24 657 679 1:CAS:528:DC%2BD28XkvFSqtLc%3D 10.1146/annurev.immunol.24.021605.090727 16551262
21. AN Theofilopoulos R Baccala B Beutler DH Kono 2005 Type I interferons (α/β) in immunity and autoimmunity Annu Rev Immunol 23 307 336 1:CAS:528:DC%2BD2MXktFOjur8%3D 10.1146/annurev.immunol.23.021704.115843 15771573 (Pubitemid 40563172)
22. SJ Allen SE Crown TM Handel 2007 Chemokine:Receptor structure, interactions, and antagonism Annu Rev Immunol 25 787 820 1:CAS:528: DC%2BD2sXltlans7o%3D 10.1146/annurev.immunol.24.021605.090529 17291188 (Pubitemid 46697924)
23. JG Cyster 2005 Chemokines, Sphingosine-1-phosphate, and cell migration in secondary lymphoid organs Annu Rev Immunol 23 127 159 1:CAS:528: DC%2BD2MXktFOjtbg%3D 10.1146/annurev.immunol.23.021704.115628 15771568 (Pubitemid 40563167)
24. N Zhang JJ Oppenheim 2005 Crosstalk between chemokines and neuronal receptors bridges immune and nervous systems J Leukoc Biol 78 1210 1214 1:CAS:528:DC%2BD2MXhtleksLrM 10.1189/jlb.0405224 16204635 (Pubitemid 41779226)
25. WA Banks MA Erickson 2010 The blood-brain barrier and immune function and dysfunction Neurobiol Dis 37 26 32 1:CAS:528:DC%2BD1MXhsVGms7vK 10.1016/j.nbd.2009.07.031 19664708
26. Y Persidsky L Poluektova 2006 Immune privilege and HIV-1 persistence in the CNS Immunol Rev 213 180 94 1:CAS:528:DC%2BD28XhtF2lsrfM 10.1111/j.1600-065X. 2006.00440.x 16972904 (Pubitemid 44401501)
27. Y Persidsky SH Ramirez J Haorah GD Kanmogne 2006 Blood-brain barrier: structural components and function under physiologic and pathologic conditions J Neuroimmune Pharmacol 1 3 223 36 10.1007/s11481-006-9025-3 18040800 (Pubitemid 44244128)
28. TK Roberts CM Buckner JW Berman 2010 Leukocyte transmigration across the blood-brain barrier: perspectives on neuroAIDS Front Biosci 15 478 536 1:CAS:528:DC%2BC3cXovFamtL4%3D 10.2741/3631 20036831
29. RN Achur WM Freeman KE Vrana 2010 Circulating cytokines as biomarkers of alcohol abuse and alcoholism J Neuroimmune Pharmacol 5 83 91 10.1007/s11481-009-9185-z 20020329
30. JM Bidlack M Khimich AL Parkhill S Sumagin B Sun CM Tipton 2006 Opioid receptors and signaling on cells from the immune system J Neuroimmune Pharmacol 1 260 269 10.1007/s11481-006-9026-2 18040803 (Pubitemid 44244131)
31. GA Cabral L Griffin-Thomas 2009 Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation Expert Rev Mol Med 11 e3 10.1017/S1462399409000957 19152719
32. TK Eisenstein RT Rahim P Feng NK Thingalaya JJ Meissler 2006 Effects of opioid tolerance and withdrawal on the immune system J Neuroimmune Pharmacol 1 237 249 10.1007/s11481-006-9019-1 18040801 (Pubitemid 44244129)
33. MJ Ferris CF Mactutus RM Booze 2008 Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS Neurosci Biobehav Rev 32 883 909 1:CAS:528:DC%2BD1cXms1Whtr4%3D 10.1016/j.neubiorev.2008.01.004 18430470
34. MJ Finley CM Happel DE Kaminsky TJ Rogers 2008 Opioid and nociceptin receptors regulate cytokine and cytokine receptor expression Cell Immunol 252 146 54 1:CAS:528:DC%2BD1cXpt1Kjtro%3D 10.1016/j.cellimm.2007.09.008 18279847
35. TW Klein GA Cabral 2006 Cannabinoid-induced immune suppression and modulation of antigen-presenting cells J Neuroimmune Pharmacol 1 50 64 10.1007/s11481-005-9007-x 18040791 (Pubitemid 44257500)
36. H Machelska C Stein 2006 Leukocyte-derived opioid peptides and inhibition of pain J Neuroimmune Pharmacol 1 90 97 10.1007/s11481-005-9002-2 18040794 (Pubitemid 44257503)
37. PE Molina 2006 Opioids and opiates: analgesia with cardiovascular, haemodynamic and immune implications in critical illness J Int Med 259 138 154 1:CAS:528:DC%2BD28XisF2qtbw%3D 10.1111/j.1365-2796.2005.01569.x
38. G Szabo P Mandrekar 2009 A recent perspective on alcohol, immunity, and host defense Alcohol Clin Exp Res 33 220 232 1:CAS:528:DC%2BD1MXivFSqtb0%3D 10.1111/j.1530-0277.2008.00842.x 19053973
39. KE Ugen SB Nyland 2006 Injecting drugs of abuse and immunity: implications for HIV vaccine testing and efficacy Springer Semin Immunopathol 28 281 7 10.1007/s00281-006-0045-0 17109182 (Pubitemid 44764283)
40. F Gonzalez-Scarano J Martin-Garcia 2005 The neuropathogenesis of AIDS Nat Rev Immunol 5 69 81 1:CAS:528:DC%2BD2MXlvVOn 10.1038/nri1527 15630430 (Pubitemid 40070332)
41. KF Hauser N El-Hage A Stiene-Martin WF Maragos A Nath Y Persidsky DJ Volsky PE Knapp 2007 HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuse J Neurochem 100 567 578 1:CAS:528:DC%2BD2sXhvFGgsbY%3D 10.1111/j.1471-4159.2006.04227.x 17173547 (Pubitemid 46095610)
42. SD Kraft-Terry AR Stothert S Buch HE Gendelman 2010 HIV-1 neuroimmunity in the era of antiretroviral therapy Neurobiol Dis 37 542 548 1:CAS:528:DC%2BC3cXitV2ktbs%3D 10.1016/j.nbd.2009.12.015 20044002
43. AJ McMichael P Borrow GD Tomaras N Goonetilleke BF Haynes 2010 The immune response during acute HIV-1 infection: clues for vaccine development Nat Rev Immunol 10 11 23 1:CAS:528:DC%2BD1MXhsFChtbnK 10.1038/nri2674 20010788
44. S Rivest 2009 Regulation of innate immune responses in the brain Nat Rev Immunol 9 429 439 1:CAS:528:DC%2BD1MXmt1SktLg%3D 10.1038/nri2565 19461673